These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26930753)

  • 1. Oral Cancer Chernoprevention: Current Status and Future Direction.
    Messadi DV; Sato K
    J Calif Dent Assoc; 2016 Feb; 44(2):101-11. PubMed ID: 26930753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
    Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
    Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.
    Meyskens FL
    Ann N Y Acad Sci; 2001 Dec; 952():116-23. PubMed ID: 11795430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronicles in drug discovery.
    Moral MA; Khurdayan VK; Bozzo J
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB; Kennedy AR; Wan XS; Atiba J; McLaren CE; Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):43-7. PubMed ID: 10667462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing biomarkers and endpoints in oral cancer chemoprevention trials.
    William WN; Papadimitrakopoulou VA
    Cancer Prev Res (Phila); 2013 May; 6(5):375-8. PubMed ID: 23639861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of difluoromethyl-ornithine and Bowman-Birk inhibitor as chemopreventive agents by assessment of relevant biomarker modulation: some lessons learned.
    Meyskens FL
    IARC Sci Publ; 2001; 154():49-55. PubMed ID: 11220668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
    Armstrong WB; Kennedy AR; Wan XS; Taylor TH; Nguyen QA; Jensen J; Thompson W; Lagerberg W; Meyskens FL
    Clin Cancer Res; 2000 Dec; 6(12):4684-91. PubMed ID: 11156220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral cancer prevention: the case for carotenoids and anti-oxidant nutrients.
    Garewal H; Meyskens F; Friedman S; Alberts D; Ramsey L
    Prev Med; 1993 Sep; 22(5):701-11. PubMed ID: 8234210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma and precursor lesions: prevention.
    Warnakulasuriya S
    Periodontol 2000; 2011 Oct; 57(1):38-50. PubMed ID: 21781178
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral Cancer: Novel Concepts for the Oral Health Care Practitioner.
    Messadi DV
    J Calif Dent Assoc; 2016 Feb; 44(2):82-4. PubMed ID: 26930750
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinoids: application in premalignant lesions and oral cancer.
    Contreras Vidaurre EG; Bagán Sebastián JV; Gavalda C; Torres Cifuentes EF
    Med Oral; 2001; 6(2):114-23. PubMed ID: 11500628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of oral premalignant lesions: concepts and implications for chemoprevention.
    Papadimitrakopoulou VA; Hong WK
    Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():87-93. PubMed ID: 9061300
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential role of beta-carotene and antioxidant vitamins in the prevention of oral cancer.
    Garewal HS
    Ann N Y Acad Sci; 1992 Sep; 669():260-7; discussion 267-8. PubMed ID: 1444031
    [No Abstract]   [Full Text] [Related]  

  • 15. Protease inhibitors in oral carcinogenesis and chemoprevention.
    Lippman SM; Matrisian LM
    Clin Cancer Res; 2000 Dec; 6(12):4599-603. PubMed ID: 11156207
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprevention of head and neck cancer.
    Gustin DM
    Semin Oncol; 2004 Dec; 31(6):769-77. PubMed ID: 15599854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin.
    Tanaka T; Makita H; Ohnishi M; Mori H; Satoh K; Hara A
    Cancer Res; 1995 Sep; 55(18):4059-64. PubMed ID: 7664280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycopene: features and potential significance in the oral cancer and precancerous lesions.
    Lu R; Dan H; Wu R; Meng W; Liu N; Jin X; Zhou M; Zeng X; Zhou G; Chen Q
    J Oral Pathol Med; 2011 May; 40(5):361-8. PubMed ID: 21198870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black tea (Camellia sinensis) as a chemopreventive agent in oral precancerous lesions.
    Halder A; Raychowdhury R; Ghosh A; De M
    J Environ Pathol Toxicol Oncol; 2005; 24(2):141-4. PubMed ID: 15831086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention.
    Monteiro de Oliveira Novaes JA; William WN
    Future Oncol; 2016 Oct; 12(20):2379-86. PubMed ID: 27329013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.